Cite
Fishbein L, Del Rivero J, Else T, et al. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021;50(4):469-493doi: 10.1097/MPA.0000000000001792.
Fishbein, L., Del Rivero, J., Else, T., Howe, J. R., Asa, S. L., Cohen, D. L., Dahia, P. L. M., Fraker, D. L., Goodman, K. A., Hope, T. A., Kunz, P. L., Perez, K., Perrier, N. D., Pryma, D. A., Ryder, M., Sasson, A. R., Soulen, M. C., & Jimenez, C. (2021). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas, 50(4), 469-493. https://doi.org/10.1097/MPA.0000000000001792
Fishbein, Lauren, et al. "The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma." Pancreas vol. 50,4 (2021): 469-493. doi: https://doi.org/10.1097/MPA.0000000000001792
Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021 Apr 01;50(4):469-493. doi: 10.1097/MPA.0000000000001792. PMID: 33939658.
Copy
Download .nbib